"From your first meeting with your care-management team to ongoing support from our survivorship program long after your treatment is complete, the health care professionals at the Graham Cancer Center are at your service."

During the past decade, Medical Oncology Hematology Consultants Helen F Graham Cancer Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Hematology Consultants Helen F Graham Cancer Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology Hematology Consultants Helen F Graham Cancer Center" are "KRAS p, G12c Mutated /Advanced Metastatic NSCLC" (1 trials), "KRAS p.G12C Mutant Advanced Solid Tumors" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Medical Oncology Hematology Consultants Helen F Graham Cancer Center" in a lesser frequency.

Most popular intervention types in "Medical Oncology Hematology Consultants Helen F Graham Cancer Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AMG 510" (1 trials), "Anti PD-1/L1" (1 trials), "Docetaxel" (1 trials), "Midazolam" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology Hematology Consultants Helen F Graham Cancer Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Medical Oncology Hematology Consultants Helen F Graham Cancer Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medical Oncology Hematology Consultants Helen F Graham Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology Hematology Consultants Helen F Graham Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".